Literature DB >> 10435768

Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee.

A Tylee1, M Gastpar, J P Lépine, J Mendlewicz.   

Abstract

DEPRES II (Depression Research in European Society II), the first in-depth, pan-European survey of depression in the community, provided an opportunity to identify depressed patient types and their treatment needs. Cluster analysis applied to data generated from DEPRES II interviews revealed six depressed patient types with clearly differentiated profiles. The patient type with moderately impaired depression has episodic depression and minimal disability. By contrast, severe depression associated with anxiety presents with chronic symptoms, including anxiety and panic, and causes considerable disruption to normal life and employment. Depression associated with chronic physical problems and depression associated with social problems are characterized by chronic physical illness and relationship or financial difficulties, respectively, and sufferers are pessimistic about recovery. Depression associated with sleep problems is associated with symptoms of tiredness and broken or inadequate sleep, and is commonly caused by stress. Tiredness is also a principal symptom of depression associated with tiredness or fatigue, but sufferers' ability to sleep is unaffected. All patient types would benefit from antidepressant therapy. The depressed patient types identified from the DEPRES II data make intuitive sense, but now need to be tested for face validity in the primary care setting.

Entities:  

Mesh:

Year:  1999        PMID: 10435768

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  11 in total

1.  Splitting antidepressant medications: more studies are needed to confirm clinical outcomes and potential savings.

Authors:  John Donoghue
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Why treat depression differently from other medical problems?

Authors:  Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 3.  Challenges in treating patients with major depressive disorder: the impact of biological and social factors.

Authors:  Soichiro Sato; Tzung Lieh Yeh
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

4.  Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.

Authors:  Samantha E Yohn; Samantha L Collins; Hector M Contreras-Mora; Emily L Errante; Margaret A Rowland; Merce Correa; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

Review 5.  Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

6.  Prevalence and correlates of mental disorders among Native American women in primary care.

Authors:  Bonnie Duran; Margaret Sanders; Betty Skipper; Howard Waitzkin; Lorraine Halinka Malcoe; Susan Paine; Joel Yager
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

Review 7.  The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation.

Authors:  Larissa N Dooley; Kate R Kuhlman; Theodore F Robles; Naomi I Eisenberger; Michelle G Craske; Julienne E Bower
Journal:  Neurosci Biobehav Rev       Date:  2018-09-07       Impact factor: 8.989

8.  Principal component and volume of interest analyses in depressed patients imaged by 99mTc-HMPAO SPET: a methodological comparison.

Authors:  Marco Pagani; Ann Gardner; Dario Salmaso; Alejandro Sánchez Crespo; Cathrine Jonsson; Hans Jacobsson; Greger Lindberg; Anna Wägner; Tore Hällström; Stig A Larsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-19       Impact factor: 9.236

9.  Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.

Authors:  Estelle Lavie; Mélina Fatséas; Jean-Pierre Daulouède; Cécile Denis; Jacques Dubernet; Laurent Cattan; Marc Auriacombe
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 10.  Fatigue as the Chief Complaint–Epidemiology, Causes, Diagnosis, and Treatment.

Authors:  Peter Maisel; Erika Baum; Norbert Donner-Banzhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 8.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.